Study on the in vitro antibacterial activities of the antibacterial drugs against methicillin resistant coagulase-negative staphylococci

Y. Yunsong,Z. Zhihui,Li Lanjuan,Z. Jingchuan,M. Yiling
1998-01-01
Abstract:Coagulase-negative staphylococci (CNS) has become the important pathogens in nosocomial infections. Most of the strains were methicillin- resistant coagulase-negative staphylococci (MRCNS). These strains had high drug resistant rate to β-lactams, macrolides and the others. Only more than 10 antibacterial drugs were recommended to treat MRCNS infections in the world. But the susceptibility were different in different districts. In order t direct the clinical treatment, 136 CNS strains were collected from nosocomial infection patients in the First and the Second Affiliated Hospital. MecA gene were positive in 107 CNS strains by PCR method. These CNS were MRCNS. The in vitro antibacterial activities of 10 antibacterial drugs against MRCNS were detected by the agar-dilution method. Results appeared that vancomycin and norvancomycin had the highest activity. Netilmicin amikacin and rifampin were the second and about 50% MRCNS were sensitive to chloramphenicol and SMZco. Ofloxacin and ciprofloxacin were recommended to treat MRCNS infections in abroad but more than 50% MRCNS were resistant to them in our study. Therefore their clinical efficacy requires further investigation.
What problem does this paper attempt to address?